Abecma OK’d in US to take earlier in treatments for multiple myeloma
The U.S. Food and Drug Administration (FDA) has expanded…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreThe U.S. Food and Drug Administration (FDA) has expanded…
Combining the cancer therapy Venclexta (venetoclax) with a molecule…
The European Commission has approved Bristol Myers Squibb…
An advisory committee of the U.S. Food and Drug…
Johnson & Johnson has applied to the…
Myeloma Action Month (MAM) is observed each March…